Cancer cell cytotoxicity of extracts and small phenolic compounds from chaga [inonotus obliquus (persoon) pilat]

Journal of Medicinal Food

Volumn 12, Issue 3, 2009, Pages 501-507

  Nakajima, Yuki ^a   Nishida, Hiroshi ^a   Matsugo, Seiichi ^b   Konishi, Tetsuya ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Anticancer; Apoptosis; Cell cycle; Medicinal mushroom

Indexed keywords

2,5 DIHYDROXYTEREPHTHALIC ACID; 3,4 DIHYDROXYBENZALACETONE; 4 HYDROXY 3,5 DIMETHOXYBENZOIC ACID 2 HYDROXY 1 HYDROXYMETHYL ETHYL ESTER; CAFFEIC ACID; CYTOTOXIC AGENT; INONTUS OBLIQUUS EXTRACT; PLANT EXTRACT; POLYPHENOL DERIVATIVE; PROTOCATECHUALDEHYDE; PROTOCATECHUIC ACID; SYRINGIC ACID; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL SELECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; FLUORESCENCE; FRUITING BODY; FUNGAL SCLEROTIUM; HUMAN; HUMAN CELL; INONTUS OBLIQUUS; MUSHROOM; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BASIDIOMYCOTA; CELL LINE, TUMOR; FEMALE; FRUITING BODIES, FUNGAL; HUMANS; NEOPLASMS; PHENOLS; PLANT EXTRACTS;

BASIDIOMYCOTA; INONOTUS OBLIQUUS;

EID: 68149092130     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.1149     Document Type: Article

References (23)

1. Shashkina M, Shashkin P, Sergeev A: Chemical and medico- biological properties of chaga. Pharm Chem J 2006;40:560-568.
2. Park YK, Lee HB, Jeon EJ, Jung HS, Kang MH: Chaga mushroom extract inhibits oxidative DNA damage in human lymphocytes as assessed by comet assay. BioFactors 2004;21:109-112.
3. Kim HG, Yoon DH, Kim CH, et al.: Ethanol extract of Inonotus obliquus inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells. J Med Food 2007;10:80-89.
4. Park YM, Won JH, Kim YH, et al.: In vivo and in vitro antiinflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol 2005;101:120-128.
5. Kim YO, Park HW, Kim JH, et al.: Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci 2006;79:72-80.
6. Nakata T, Yamada T, Taji S, et al.: Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. Bioorg Med Chem 2007;15:257-264.
7. Kablos K, Kangas L, Hiltunen R: Antitumour tests of inotodiol from the fungus Inonotus obliquus. Acta Pharm Fenn 1986;95:173-177.
8. Zjawiony JK: Biologically active compounds from Aphyllo- phorales (polypore) fungi. J Nat Prod 2004;67:300-310.
9. Kim YO, Han SB, Lee HW, et al.: Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of In- onotus obliquus. Life Sci 2005;77:2438-2456.
10. Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS: Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides 2006;27:1173-1178.
11. Lee I-K, Kim Y-S, Jang Y-W, Jung J-Y, Yun B-S: New anti- oxidant polyphenols from the medicinal mushroom Inonotus obliquus. Bioorg Med Chem Lett 2007;17:6678-6681.
12. Nakajima Y, Sato Y, Konishi T: Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga). Chem Pharm Bull (Tokyo) 2007;55:1222-1226.
13. Kahlos K, Kangas L, Hiltunen R: Antitumor activity of tri- terpenes in Inonotus obliquus. Planta Med 1986;52:554.
14. Kahlos K, Hiltunen R: 3β,22-Dihydroxylanosta-7,9(11),24- triene: a new, minor compound from Inonotus obliquus. Planta Med 1986;52:495-496.
15. Kahlos K, Hiltunen R, von Schantz M: 3β-Hydroxy-lanosta-8,24- dien-21-al, a new triterpene from Inontus obliquus. Planta Med 1984;50:197-198.
16. Taji S, Yamada T, In Y, et al.: Three new lanostane triterpenoids from Inonotus obliquus. Helv Chimica Acta 2007;90:2047-2057.
17. Mizuno T, Zhuang C, Abe K, et al.: Studied on the host-mediated antitumor polysaccharides. Part XX-VII. Antitumor and hypo- glycemic activities of polysaccharides isolated from sclerotium Charga and mycelium of Fuscopria obliqua mushroom fungus. Mushroom Sci Technol 1996;3:8.
18. Nishida H, Kushida M, Nakajima Y, et al.: Amyloid-beta- induced cytotoxicity of PC-12 cell was attenuated by Shengmai- san through redox regulation and outgrowth induction. J Pharmacol Sci 2007;104:73-81.
19. Fiuza SM, Gomes C, Teixeira LJ, et al.: Phenolic acid derivatives with potential anticancer properties-a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem 2004;12:3581-3589.
20. Edinger AL, Thompson CB: Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004;16:663-669.
21. Amaravadi RK, Thompson CB: The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 2007;13:7271-7279.
22. Sung B, Pandey MK, Nakajima Y, et al.: Identification of a novel blocker of IκBα kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor- κB. Mol Cancer Ther 2008;7:191-201.
23. Youn MJ, Kim JK, Park SY, et al.: Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepa-toma HepG2 cells. World J Gastroenterol 2008;14:511-517.